A carregar...
Breast Cancer in 2013: Genomics, drug approval pathways, and optimal treatment duration
2013 was another rich year for breast cancer research. Advances in high throughput technologies continue to refine our knowledge of the molecular biology of breast cancer, and are beginning to give insight into cancer evolution, drug resistance, and deployment of precision therapeutics.
Na minha lista:
| Publicado no: | Nat Rev Clin Oncol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4677672/ https://ncbi.nlm.nih.gov/pubmed/24419301 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrclinonc.2013.250 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|